Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited thrombotic disorders: an update

S R Florell1, G M Rodgers

  • 1Department of Pathology, University of Utah Health Sciences Center, Salt Lake City 84132, USA.

American Journal of Hematology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Evaluation of a new commercial method for von Willebrand factor multimeric analysis.

International journal of laboratory hematology·2018
Same author

Implementation of a recombinant factor IX Fc fusion protein extended-infusion desensitization protocol.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

A high-performance liquid chromatography method for the serotonin release assay is equivalent to the radioactive method.

International journal of laboratory hematology·2015
Same author

A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).

Journal of thrombosis and haemostasis : JTH·2015
Same author

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: comment.

Journal of thrombosis and haemostasis : JTH·2015
Same journal

Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait.

American journal of hematology·2026
Same journal

POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management.

American journal of hematology·2026
Same journal

EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.

American journal of hematology·2026
Same journal

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

American journal of hematology·2026
Same journal

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

American journal of hematology·2026
Same journal

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

American journal of hematology·2026
See all related articles

Recent advances identify genetic factors like factor V Leiden and homocysteinemia as key inherited causes of thrombosis. Recognizing these improves diagnosis for many patients with recurrent blood clots.

Area of Science:

  • Genetics
  • Hematology
  • Molecular Biology

Background:

  • Inherited thrombosis predisposes individuals to dangerous blood clots.
  • Previous understanding of genetic thrombotic risk factors was limited.

Purpose of the Study:

  • To highlight recent discoveries in the genetic etiologies of inherited thrombosis.
  • To emphasize the diagnostic implications of these findings.

Main Methods:

  • Review of recent scientific literature on inherited thrombotic disorders.
  • Analysis of genetic mutations and metabolic pathways associated with thrombosis.

Main Results:

  • Factor V Leiden mutation identified as a common genetic risk factor for venous thrombosis.

Related Experiment Videos

  • Homocysteinemia recognized as a significant risk factor for both arterial and venous thrombosis.
  • Multiple genetic risk factors are often present in patients with recurrent thrombosis.

    • Conclusions:

    • New diagnostic approaches can identify the causes of inherited thrombosis in over half of evaluated patients.
    • Understanding these genetic factors is crucial for managing and preventing thrombotic events.